Subtype

Pancreatic Carcinoma

488 active trials5 approved drugs31 evidence items

NCIt: C207229
DOID: 4905

Clinical trials

Registered studies

1,381 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 488
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +31.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

No study matches these filters